BSGM - BioSig Technologies, Inc.


0.4778
-0.052   -10.925%

Share volume: 33,641
Last Updated: 04-08-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$0.53
-0.05
-0.10%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
15%
Profitability 0%
Dept financing 25%
Liquidity 9%
Performance 30%
Company vs Stock growth
vs
N/A
0.510 1.580
1.070 209.8%
Performance
5 Days
-7.22%
1 Month
-41.01%
3 Months
-66.82%
6 Months
76.96%
1 Year
-70.51%
2 Year
-95.85%
Key data
Stock price
$0.48
P/E Ratio 
0.00
DAY RANGE
$0.45 - $0.53
EPS 
-$1.60
52 WEEK RANGE
$0.20 - $2.57
52 WEEK CHANGE
-$76.23
MARKET CAP 
4.212 M
YIELD 
N/A
SHARES OUTSTANDING 
16.278 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
3.58
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$81,780
AVERAGE 30 VOLUME 
$224,909
Company detail
CEO: Kenneth L. Londoner
Region: US
Website: biosig.com
Employees: 50
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system. PURE EP is a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition.

Recent news
loading